Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Sobue

Showing results (71-80 of 632) with videos related to

Pageof 64
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 10, 2014
[Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS)]Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 11, 2004
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectivesMasahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 12, 2004
[Cognitive impairment in patients with multiple system atrophy]Hirohisa Watanabe, Akinori Takeda, Yoshinari Kawai, et al.
Journal of Neurology|January 12, 2015
Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trialHaruki Koike, Kazuo Akiyama, Toyokazu Saito, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 25, 2009
[Exploration of pathogenesis and therapy development for ALS employing sporadic disease model]Fumiaki Tanaka, Masahiro Waza, Masahiko Yamamoto, et al.
Acta Neuropathologica|March 8, 2003
Clinical and neuropathological correlates of Lewy body diseaseNozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 10, 2004
[Development of the treatment for bulbospinal muscular atrophy]Masahisa Katsuno, Hiroaki Adachi, Haruhiko Hanno, et al.
Expert Review of Neurotherapeutics|September 6, 2014
Potential therapeutic targets in polyglutamine-mediated diseasesMasahisa Katsuno, Hirohisa Watanabe, Masahiko Yamamoto, et al.
Neurogenetics|October 31, 2003
Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in JapanMasahiko Yamamoto, Tsuyoshi Yoshihara, Naoki Hattori, et al.
Journal of the Peripheral Nervous System : JPNS|June 24, 2011
Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathyMasahiro Iijima, Haruki Koike, Masahisa Katsuno, et al.
Pageof 64

Showing results (71-80 of 632) with videos related to

Sort By:
Pageof 64
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 10, 2014
[Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS)]Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 11, 2004
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectivesMasahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 12, 2004
[Cognitive impairment in patients with multiple system atrophy]Hirohisa Watanabe, Akinori Takeda, Yoshinari Kawai, et al.
Journal of Neurology|January 12, 2015
Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trialHaruki Koike, Kazuo Akiyama, Toyokazu Saito, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 25, 2009
[Exploration of pathogenesis and therapy development for ALS employing sporadic disease model]Fumiaki Tanaka, Masahiro Waza, Masahiko Yamamoto, et al.
Acta Neuropathologica|March 8, 2003
Clinical and neuropathological correlates of Lewy body diseaseNozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 10, 2004
[Development of the treatment for bulbospinal muscular atrophy]Masahisa Katsuno, Hiroaki Adachi, Haruhiko Hanno, et al.
Expert Review of Neurotherapeutics|September 6, 2014
Potential therapeutic targets in polyglutamine-mediated diseasesMasahisa Katsuno, Hirohisa Watanabe, Masahiko Yamamoto, et al.
Neurogenetics|October 31, 2003
Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in JapanMasahiko Yamamoto, Tsuyoshi Yoshihara, Naoki Hattori, et al.
Journal of the Peripheral Nervous System : JPNS|June 24, 2011
Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathyMasahiro Iijima, Haruki Koike, Masahisa Katsuno, et al.
Pageof 64